Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients

被引：0
|
作者：
Xu, C. [1 ]
Wang, W. [2 ]
Zhang, Q. [3 ]
Zhuang, W. [4 ]
Zhu, Y. [5 ]
Huang, Y. [4 ]
Chen, Y. [3 ]
Chen, G. [3 ]
Fang, M. [2 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构：
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Fujian Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Non-small-cell lung cancer; Prognosis; ESR1; mutation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-08
引用
收藏
页码：S913 / S913
页数：1
相关论文
共 50 条
  • [21] Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer
    Kim, Jung Soo
    Cho, Min Seong
    Nam, Jong Hyeon
    Kim, Hyun-Jung
    Choi, Kyeng-Won
    Ryu, Jeong-Seon
    PLOS ONE, 2017, 12 (05):
  • [22] PROGNOSTIC IMPACT OF EGFR MUTATION IN NON-SMALL-CELL LUNG CANCER PATIENTS WITH FAMILY HISTORY OF LUNG CANCER
    Kwak, S. M.
    Soo, K. Jung
    Ryu, J. S.
    RESPIROLOGY, 2016, 21 : 111 - 111
  • [23] The Frequency and Prognosis of ATM Mutations in Chinese Non-Small-Cell Lung Cancer Patients
    Han, C.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Y.
    Chen, Y.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S521 - S521
  • [24] Treating advanced non-small-cell lung cancer in Chinese patients: focus on icotinib
    Liang, Jun-Li
    Ren, Xiao-Cang
    Lin, Qiang
    ONCOTARGETS AND THERAPY, 2014, 7 : 761 - 769
  • [25] Analysis of the EGFR gene mutation in patients with non-small cell lung cancer in a Chinese population
    Li, Ju-yi
    Liu, Ying
    Deng, Ai-ping
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (08) : 1637 - 1641
  • [26] Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
    Li, Wei
    Zhou, Fei
    Zhou, Caicun
    ONCOTARGETS AND THERAPY, 2014, 7 : 253 - 261
  • [27] Role of gefitinib in the targeted treatment of non-small-cell lung cancer in Chinese patients
    Li, Meng-Jiao
    He, Qing
    Li, Mei
    Luo, Feng
    Guan, Yong-Song
    ONCOTARGETS AND THERAPY, 2016, 9 : 1291 - 1302
  • [28] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [29] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [30] Survival and mutational differences based on ESR1 and ESR2 expression in non-small cell lung cancer (NSCLC)
    Hsu, Robert
    Leyba, Alexis
    Chen, Denaly
    Krause, Harris Benjamin
    Elliott, Andrew
    Cozen, Wendy
    Torres, Evanthia T. Roussos
    Nagasaka, Misako
    Mamdani, Hirva
    Lopes, Gilberto
    Borghaei, Hossein
    Liu, Stephen V.
    Ma, Patrick C.
    Vanderwalde, Ari M.
    Nieva, Jorge J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345